New England Journal of Medicine

A general medical journal. CLARITY AD was published here. Listing the journal is not an endorsement of every paper it carries.

Used so the graph can point from the CLARITY AD paper to its venue.

Publisher

Massachusetts Medical Society

Scope

General medicine, including pivotal clinical trials

Website

Access model

hybrid

Key papers

This is the main published efficacy trial behind the US traditional approval of lecanemab. A mean scale change is not a promise for one person.

This is the main published efficacy trial behind the US traditional approval of lecanemab. A mean scale change is not a promise for one person.